Our Company is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections. We offer wide range of pharmaceuticals formulation products, of which around 120 products are marketed by us under our own brand name, the manufacturing of which is outsourced by us to third parties. Apart from pharmaceutical formulation products, we also deal in trading of active pharmaceutical ingredients (API’s).
Mr. Bhumishth Narendrabhai Patel and Mrs. Payal Bhumishth Patel are the key promoters of our company. Our promoters collectively have more than four decades of experience among them. Our Company was originally incorporated as “Earum Pharmaceuticals Private Limited” on July 26, 2012 at Ahmedabad, Gujarat under the provisions of the Companies Act, 1956. On January 23, 2019, our company was converted into a Public Limited Company and consequently the name of our Company was changed from “Earum Pharmaceuticals Private Limited” to “Earum Pharmaceuticals Limited”.
Mr. Bhumishth Narendrabhai Patel and Mrs. Payal Bhumishth Patel are the key promoters of our company. Our promoters collectively have more than four decades of experience among them. Our Company was originally incorporated as “Earum Pharmaceuticals Private Limited” on July 26, 2012 at Ahmedabad, Gujarat under the provisions of the Companies Act, 1956. On January 23, 2019, our company was converted into a Public Limited Company and consequently the name of our Company was changed from “Earum Pharmaceuticals Private Limited” to “Earum Pharmaceuticals Limited”.
Earum Pharmaceuticals Limited IPO Details
|
|
---|---|
Issue Open | 21-06-2019 |
Issue Close | 26-06-2019 |
Allotment Date | 02-07-2019 |
Unblocked Amount | 03-07-2019 |
Listing Date | 04-07-2019 |
Issue Share | 18,48,000 Total Equity Share 96,000 Reserved by Market Maker 17,52,000 Equity Share |
Issue Size | ₹ 6.65 Cr |
IPO Price Band | ₹ 36 |
Minimum Share Bid | 3000 |
Minimum Investment Amount [Rs] | ₹ 1,08,000 |
Face Value | ₹ 10 |
Retail Allocation | 50% |
Listing On | BSE SME |
Earum Pharmaceuticals Limited IPO Grey Market Premium GMP]
|
||||
---|---|---|---|---|
Latest Update | Premium | Kostak | Subject to Sauda | Recommended |
24-06-2019 : 08:00 AM | - | - | - | - |
Earum Pharmaceuticals Limited IPO Financial details [in Rs, Cr]
|
||||
---|---|---|---|---|
Financial Year | Total Assets | Total Revenue | Total Expenses | Profit After Tax |
FY-2014 | - | - | - | - |
FY-2015 | - | - | - | - |
FY-2016 | 8.79 | 18.63 | 18.47 | 0.09 |
FY-2017 | 11.08 | 23.70 | 23.45 | 0.15 |
FY-2018 | 20.53 | 35.85 | 34.60 | 0.85 |
31/12/18 | 27.42 | 34.50 | 33.30 | 0.86 |
Earum Pharmaceuticals Limited IPO Valuation Details
|
|
---|---|
Earnings Per Share [EPS] | ₹ 3.50 |
Price/Earnings [P/E] Ratio | 10.29 |
Return on Net Worth [RoNW] | 20.34 % |
Net Asset Value [NAV] | ₹ 136.46 Per Share |
Earum Pharmaceuticals Limited IPO Subscription Details
|
|||
---|---|---|---|
As on Date | QIB/NII | RII | Total |
Shared Offered | 8,76,000 | 8,76,000 | 17,52,000 |
Day-1 [21-06-2019] | 10,14,000 [1.16] | 18,000 [0.02] | 10,32,000 [0.77] |
Day-2 [24-06-2019] | 11,31,000 [1.29] | 2,19,000 [0.25] | 13,50,000 [0.77] |
Day-3 [25-06-2019] | 12,75,000 [1.46] | 5,94,000 [0.68] | 18,69,000 [1.07] |
Day-4 [26-06-2019] | 15,03,000 [1.72] | 12,99,000 [1.48] | 28,02,000 [1.60] |
Earum Pharmaceuticals Limited IPO Grey Market Premium
|
---|
Check Grey Market Premium :- Click Here |
Earum Pharmaceuticals Limited IPO Allotment Status
|
---|
Check Allotment Status :- Click Here |
Live Subscription for Earum Pharmaceuticals Limited IPO
|
---|
Check Live Subscription :- Click Here |
Download Earum Pharmaceuticals Limited IPO RHP & ASBA e-Forms
|
---|
Download RHP :- Click Here to Download Download e-Forms BSE:- Click Here to Download |
Earum Pharmaceuticals Limited IPO Recommendations
|
---|
Live IPO Team Recommendation:- Neutral |
Earum Pharmaceuticals Limited IPO Contact Details
|
---|
Earum Pharmaceuticals Limited
G1, Ground Floor, V R Complex, Near Sanathal Cross Road, SP Ring Road, Sanathal, Ahmedabad, Gujarat-382210, India. Tel No: +91-79-48402525 E-mail: cs@earumpharma.com Website: https://www.earumpharma.com |
Registrar of Earum Pharmaceuticals Limited IPO
|
---|
BIGSHARE SERVICES PRIVATE LIMITED
Address:-1st Floor, Bharat Tin Works Building, Opp. Vasant Oasis, Makwana Road, Marol, Andheri East, Mumbai - 400059 Tel No.:+91-022-62638200Fax No.: +91-022-62638299 Website:www.bigshareonline.com Email:ipo@bigshareonline.com Contact Person: Mr. Ashok Shetty SEBI Regn. No.: INR000001385 |
Lead Managers of Earum Pharmaceuticals Limited IPO
|
---|
HEM SECURITIES LIMITED
904,A Wing, Naman Midtown, Senapati Bapat Marg, Elphinstone Road, Lower Parel, Mumbai-400013, India Tel. No.: +91- 022- 49060000Fax No.: +91- 022- 22625991 Website: www.hemsecurities.com Email: ib@hemsecurities.com Investor Grievance Email: redressal@hemsecurities.com Contact Person :Mr. Anil Bhargava SEBI Regn. No. INM000010981 |
Disclaimer:-
|
---|
• I request all investors, before applying for any IPO, please check the fundamentals and financial condition of the company and then applying to any IPO.
• www.liveipo.in will not be responsible for any kind of losses. So apply to any IPO at your risk
• We are not buying or selling any IPO forms regarding IPO Grey Market premium. We are only provide only recommendation of any IPO.
• Please do not subscribe to any IPO by just seeing the Grey Market Premium Price. It can change at any time.
|
0 Response to "Earum Pharmaceuticals Limited IPO Details"
Post a Comment